Navigation Links
Boston Scientific to Present at 29th Annual J.P. Morgan Healthcare Conference

NATICK, Mass., Dec. 27, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco.

Ray Elliott, President and Chief Executive Officer, will make a 25-minute presentation on Tuesday, January 11, 2011, beginning at approximately 9:30 a.m. PT.  Following the presentation, Jeff Capello, Executive Vice President and Chief Financial Officer, will join Mr. Elliott in a question and answer session.

A live webcast of the presentation and question and answer session will be available to all interested parties on Boston Scientific's website at Please visit the website for details on how to access the webcast.  To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins.

A replay of the webcast will be archived and available on the Investor Relations site at shortly after the completion of the question and answer session.

About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit:   CONTACT:

Paul Donovan508-650-8541 (office)508-667-5165 (mobile)Media RelationsBoston Scientific CorporationLarry Neumann508-650-8696 (office)Investor RelationsBoston Scientific CorporationSean Wirtjes508-652-5305 (office)Investor RelationsBoston Scientific Corporation

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
2. Boston Scientific Welcomes Publication of Analysis of Patients Monitored by the LATITUDE® Patient Management System
3. EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino
4. SIGVARIS Provides Red Socks to Honor Efforts by Boston Red Sox Manager, Terry Francona, to Raise Awareness for DVT Prevention
5. PAREXEL International to Participate in the Lazard Capital Markets Healthcare Conference in New York and the Jefferies Healthcare Summit in Boston
6. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
7. Boston Scientific Completes Acquisition of Asthmatx
8. Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex® Biliary RX Stent
9. Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix™ Biliary Stents
10. Boston Scientific Announces Results for Third Quarter Ended September 30, 2010
11. Boston Scientific Announces Global Launch of Journey™ Guidewire
Post Your Comments:
(Date:10/10/2017)... 10, 2017  NDS received FDA 510(k) clearance in May 2017 ... display stand specifically designed for endoscopy environments. An innovative secondary monitor ... clinical solution to support the improvement of patient outcomes, procedural efficiency, ... ... ...
(Date:10/7/2017)... --  Provista, a proven leader in the supply ... power, today announced a new resource area on ... is the online home for case studies, articles on ... releases, slideshows and events. ... at their fingertips, viewers can also watch short videos ...
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):